Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0660
0.00 (0.00%)
Jun 26, 2026, 1:49 PM AEST
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 79.78 million as of June 26, 2026. Its market cap has decreased by -14.75% in one year.
Market Cap
79.78M
Enterprise Value
60.41M
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 79.78M, an increase of 351.37%. That is a compound annual growth rate of 6.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 79.78M | -28.58% |
| Dec 31, 2025 | 111.71M | -37.97% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 123.08M |
| Actinogen Medical | 120.71M |
| Island Pharmaceuticals | 115.41M |
| Nyrada | 105.33M |
| LTR Pharma | 102.70M |
| Paradigm Biopharmaceuticals | 89.33M |
| Avecho Biotechnology | 80.44M |
| Immutep | 76.63M |